Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research 23 January 2026
Verici Dx landmark deal unlocks potential $300 million Tutivia market – Singer research ICYMI 22 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video)
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research 23 January 2026
Verici Dx landmark deal unlocks potential $300 million Tutivia market – Singer research ICYMI 22 January 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
Liquidia Corporation (LQDA) Stock Analysis: A Biotech Contender with a Stunning 1,121.70% Revenue Growth 16 December 2025
Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Reveals a 52.89% Potential Upside 16 December 2025
Evotec SE (EVO) Stock Analysis: Exploring an 87.54% Potential Upside Amid Challenging Metrics 16 December 2025
ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unveiling a Potential 170% Upside in Biotech 16 December 2025
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Navigating Growth Challenges with Innovation 16 December 2025
Omnicell, Inc. (OMCL) Stock Analysis: Exploring a Potential 19% Upside in the Healthcare Sector 16 December 2025
Arcellx, Inc. (ACLX) Investor Outlook: Exploring a Promising 65.53% Upside Potential in Biotechnology 16 December 2025
Warby Parker Inc. (WRBY) Stock Analysis: A Closer Look at its 15.2% Revenue Growth and Market Position 16 December 2025
Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a Potential 15% Upside for Forward-Thinking Investors 16 December 2025
Certara, Inc. (CERT) Stock Analysis: A 47% Upside Potential Awaits in the Healthcare Sector 16 December 2025
Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a 77% Potential Upside in Biotech 16 December 2025
Celldex Therapeutics (CLDX) Stock Analysis: Exploring the 96% Potential Upside in Biotechnology 16 December 2025
Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Exploring a Promising 31.68% Upside Potential 16 December 2025
Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Uncovering a 46% Potential Upside in the Biotech Sphere 16 December 2025
Ligand Pharmaceuticals (LGND) Stock Analysis: Unveiling a 26% Potential Upside in the Biotech Sector 16 December 2025
National HealthCare Corporation (NHC) Stock Analysis: Exploring the Healthcare Giant’s Solid Revenue Growth and Dividend Reliability 16 December 2025
Progyny, Inc. (PGNY): Investor Outlook Reveals 11.62% Potential Upside in the Healthcare Sector 16 December 2025
Mesoblast Limited (MESO) Stock Analysis: Exploring a Potential 97.63% Upside in Regenerative Medicine 16 December 2025
Arcutis Biotherapeutics, Inc. (ARQT) Stock Report: Exploring a 9.24% Potential Upside Amid Robust Growth 16 December 2025
Enovis Corporation (ENOV) Stock Analysis: Exploring an 81% Upside Potential in the Medical Device Sector 16 December 2025
NB Private Equity Returns Stay Strong as Exit Pipeline Builds and Buybacks Accelerate (Video) 19 December 2025
Oriole Resources: Technical Submission at Bibemi Sparks Momentum Toward First Exploitation Licence (Video) 17 December 2025
Peter Cruddas CEO CMC Markets: Building a Fintech Powerhouse from London to Sydney (Video) 11 December 2025
The Artisanal Spirits Company Sees Stabilisation and Growth Potential, Says Panmure Liberum 26 January 2026
Record Reports Strong Q3 Growth Driven by Net Flows and Asset Gains – Edison Investment Research 23 January 2026
Verici Dx landmark deal unlocks potential $300 million Tutivia market – Singer research ICYMI 22 January 2026
Ampeak Energy Welcomes New Strategic Shareholder in Positive Step Forward, says Longspur Research 23 February 2026
Drax Group’s Second Tolling Agreement Builds Momentum In Battery Storage, says Longspur Research 20 February 2026
Vistry Group PLC (VTY.L) Stock Analysis: Navigating Challenges with Strategic Resilience 2 March 2026
PRUDENTIAL PLC ORD 5P (PRU.L) Stock Analysis: Unveiling a 19.99% Upside Potential for Investors 2 March 2026
UNITE GROUP PLC ORD 25P (UTG.L) Stock Report: Evaluating a 36.93% Potential Upside for Investors 2 March 2026
